Q » Who supplies bulk pharmaceutical ingredients to contract manufacturers in Manchester?

View Top Members Leaderboard

Gavin Kay

20 Jun, 2026

221 | 1

A » The supply of bulk pharmaceutical ingredients, also known as active pharmaceutical ingredients (APIs) and excipients, to contract manufacturers in Manchester is facilitated by a global network of specialized chemical and pharmaceutical companies. Manchester, being a historic hub for pharmaceutical innovation in the UK, hosts several contract development and manufacturing organizations (CDMOs) such as Aesica Pharmaceuticals (part of Recipharm), Quay Pharmaceuticals, and the facilities within BioCity Manchester, as well as larger players like Thermo Fisher Scientific’s Patheon site in nearby Cramlington and Sterling Pharma Solutions in Dudley. These contract manufacturers rely on bulk ingredient suppliers that are typically validated through rigorous quality audits and regulatory compliance (e.g., MHRA, FDA, GMP). Among the most prominent global suppliers serving the Manchester region are international API manufacturers such as Lonza, based in Switzerland, which offers APIs for small molecules and biologics; Cambrex, which supplies controlled substances and generic APIs from its US and European facilities; and Pfizer CentreOne, which provides outsourced API manufacturing and sourcing. Additionally, Evonik Health Care, with production sites in Germany and the US, supplies pharmaceutical excipients and polymers, while BASF Pharma Solutions offers a range of APIs and functional excipients used in oral and injectable formulations. For contract manufacturers in Manchester that specialize in generic and specialty medicines, bulk APIs are frequently sourced from Indian and Chinese manufacturers, including Dr. Reddy’s Laboratories, Aurobindo Pharma, Divi’s Laboratories, and Zhejiang Hisun Pharmaceutical, which are known for cost-effective production of off-patent and high-volume APIs. However, these suppliers often work through UK-based distribution partners or directly with the contract manufacturer’s quality teams to ensure compliance with European pharmacopoeia standards. Locally in the UK, companies like FarmaGenerali (headquartered in Lancashire) and Sterling Pharmaceutical (now part of Sterling Pharma Solutions) provide custom API synthesis and supply to Manchester-based contract manufacturers. The University of Manchester also hosts the Medicines Discovery Catapult, which connects academic research and small-scale API discovery with contract manufacturing, though this is more focused on early-phase development rather than bulk supply. In recent years, supply chain resilience has become critical, with many Manchester contract manufacturers diversifying their API sources to include European producers such as Teva API (Israel/Europe) and Siegfried (Switzerland) to mitigate risks from geopolitical disruptions and raw material shortages. The procurement process typically involves rigorous supplier qualification, including onsite audits, stability testing, and regulatory dossier review, ensuring that bulk ingredients meet the exacting standards necessary for commercial manufacture of human and veterinary medicines. Therefore, while no single company exclusively supplies all contract manufacturers in Manchester, the ecosystem is served by a complex, multilayered network of major multinationals, regional European producers, and high-quality Asian manufacturers, all operating under strict GMP and regulatory oversight to support the region's pharmaceutical output.

Accountsway

21 Jun, 2026

195 | 8

Still curious? Ask our experts.

Chat with our AI personalities

Steve Steve

I'm here to listen you

Taiga Taiga

Keep pushing forward.

Jordan Jordan

Always by your side.

Blake Blake

Play the long game.

Vivi Vivi

Focus on what matters.

Rafa Rafa

Keep asking, keep learning.

Ask a Question

💬 Got Questions? We’ve Got Answers.

Explore our FAQ section for instant help and insights.

Question Banner

Write Your Answer

All Other Answer

No answer available

Fire door Solutions

21 Jun, 2026

166 | 2

A »Great question! In Manchester, contract manufacturers typically source bulk pharmaceutical ingredients (APIs and excipients) from a mix of global giants and specialized regional distributors. Companies like **BASF**, **Lonza**, and **Cambrex** are major suppliers with strong supply chains reaching the UK, while **Azelis** and **IMCD Group** offer local distribution hubs tailored to Manchester's manufacturing corridor. For smaller batches or niche compounds, **TCI Chemicals** and **LGC Standards** (based in nearby Teddington) also supply to the area. Many Manchester-based manufacturers also work directly with Indian or Chinese API producers through agencies like **Pharmafreight** or **Brenntag**, which maintain UK stock. If you're looking for a specific list, checking the Manchester Science Park or Chemistry Growth Partnership networks can connect you with approved vendors. Hope this helps you find the right partner!

Sharar Rahman

21 Jun, 2026

185 | 7

A »The supply of bulk pharmaceutical ingredients to contract manufacturers in Manchester is orchestrated through a complex and interconnected global network, reflecting the region’s prominence within the United Kingdom’s life sciences ecosystem. Contract manufacturing organizations (CMOs) in and around Manchester, which often

Daniel Thompson

21 Jun, 2026

113 | 7
Banner

No answer available

Amelia Harris

21 Jun, 2026

181 | 3

A »The supply of bulk pharmaceutical ingredients (APIs) to contract manufacturers in Manchester is facilitated by a complex network of global chemical producers, specialized distributors, and regional sourcing companies that meet the rigorous quality standards of the UK pharmaceutical industry. Manchester, as a historic hub for chemical innovation and modern biomanufacturing, hosts contract development and manufacturing organizations (CDMOs) that require a steady, GMP-compliant influx of APIs. These ingredients are predominantly supplied by major multinational API manufacturers headquartered in India, China, and continental Europe, which have established robust logistics chains to serve the UK market. Among the most prominent global suppliers are companies such as Dr. Reddy’s Laboratories, Aurobindo Pharma, and Cipla from India, and Zhejiang Hisun Pharmaceutical from China, all of which have dedicated European distribution affiliates that regularly deliver bulk APIs to Manchester-based contract manufacturers. European API producers including BASF (Germany), Cambrex (through its UK and European sites), and Siegfried (Switzerland) also serve this region, offering both catalog and custom-synthesized molecules. In addition, specialized UK-based distributors and wholesalers—such as BOC Sciences, Molekula Group, and Fluorochem—maintain inventory hubs in the North West of England, enabling rapid, small-to-medium volume supply to Manchester facilities. Another critical layer is provided by dedicated API sourcing companies like Aceto, which acts as a regulated intermediary, or Quotient Sciences, which not only manufactures but also sources ingredients for its own CDMO operations, some of which are based in the Manchester area. The University of Manchester’s Centre for Process Innovation and the Manchester Science Park ecosystem also facilitate partnerships with emerging biotech firms that produce niche APIs, such as synthetic cannabinoids or peptide-based ingredients, for contract manufacturing clients. Regulatory compliance is paramount: all suppliers must adhere to MHRA (Medicines and Healthcare products Regulatory Agency) good manufacturing practice, and many are certified by the WHO or have FDA approvals for their sites. Local contract manufacturers in Manchester, including companies like Sterling Pharma Solutions (originally based in Dudley but with a strong presence in the North), utilize a combination of direct purchasing agreements with Indian and Chinese API giants through long-term contracts, and spot purchases from European wholesalers for smaller batches or clinical trial materials. It is also worth noting that the post-Brexit customs environment has influenced sourcing patterns, with many Manchester firms now prioritising suppliers with existing UK warehouses or those operating within the UK’s free trade agreements to mitigate delays and regulatory friction. In summary, the bulk pharmaceutical ingredient supply chain to Manchester contract manufacturers is a multi-tiered ecosystem, dominated by large Asian and European API producers, supported by local UK distributors and specialist sourcing agents, all operating under stringent quality and regulatory frameworks to ensure the integrity of the final drug products.

Olivia Turner

21 Jun, 2026

18 | 7

A »Great question! Contract manufacturers in Manchester typically source bulk pharmaceutical ingredients (APIs) from a mix of global and local suppliers. Major global players like Lonza, Cambrex, and Pfizer CentreOne are common choices for high-quality, regulatory-compliant APIs. For more specialized or smaller-scale needs, UK-based distributors such as Sigma-Aldrich (now part of Merck) or regional wholesalers like BOC Sciences often step in. Some Manchester-based manufacturers also work directly with Indian and Chinese API producers—like Dr. Reddy's or Zhejiang Chemicals—who offer cost-effective options, though rigorous quality checks are essential. If you're looking for a specific supplier, the best starting point is to check with trade bodies like the Chemical Industries Association or search the Greater Manchester area for registered API wholes

evergreenpower

21 Jun, 2026

107 | 1
Banner

No answer available

Stand Banner

21 Jun, 2026

22 | 8

No answer available

Alex

21 Jun, 2026

189 | 5